Press "Enter" to skip to content

Bayer seeks approval to treat children with blockbuster drug Xarelto

Bayer added that it would submit an application to the European Medicines Agency for an extension of the Xarelto marketing authorisation. It did not give a timeframe.

Original source:

Also Read:   Japan's AnGes begins Phase 2 clinical trials of DNA vaccine against Covid-19